SIG-002
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 07, 2023
Shielded Living Therapeutics platform for the treatment of type 1 diabetes
(IPITA-IXA-CTRMS 2023)
- "We have shown that SIG-002 is efficacious and that Afibromer alginate mitigates the foreign body response. With these encouraging preclinical data, we have laid the foundation for achieving our goal of developing a functional cure for T1D."
Diabetes • Fibrosis • Metabolic Disorders • Type 1 Diabetes Mellitus
1 to 1
Of
1
Go to page
1